These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33099846)

  • 1. What are the patients' and health care professionals' understanding and behaviors towards adverse drug reaction reporting and additional monitoring?
    Januskiene J; Segec A; Slattery J; Genov G; Plueschke K; Kurz X; Arlett P
    Pharmacoepidemiol Drug Saf; 2021 Mar; 30(3):334-341. PubMed ID: 33099846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knowledge of Adverse Drug Reaction Reporting and the Pharmacovigilance of Biological Medicines: A Survey of Healthcare Professionals in Ireland.
    O'Callaghan J; Griffin BT; Morris JM; Bermingham M
    BioDrugs; 2018 Jun; 32(3):267-280. PubMed ID: 29721705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with spontaneous adverse drug reaction reporting among healthcare professionals in Vietnam.
    Le TT; Nguyen TTH; Nguyen C; Tran NH; Tran LA; Nguyen TB; Nguyen N; Nguyen HA
    J Clin Pharm Ther; 2020 Feb; 45(1):122-127. PubMed ID: 31486525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation.
    Aziz AA; Rogers S; Hassanien O; Shalaby L; Nagy M
    Per Med; 2022 Nov; 19(6):495-507. PubMed ID: 36239598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Scenario and Future Prospects of Adverse Drug Reactions (ADRs) Monitoring and Reporting Mechanisms in the Rural Areas of India.
    Shukla S; Sharma P; Gupta P; Pandey S; Agrawal R; Rathour D; Kumar Kewat D; Singh R; Kumar Thakur S; Paliwal R; Sulakhiya K
    Curr Drug Saf; 2024; 19(2):172-190. PubMed ID: 37132145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reporting, Monitoring, and Handling of Adverse Drug Reactions in Australia: Scoping Review.
    Fossouo Tagne J; Yakob RA; Dang TH; Mcdonald R; Wickramasinghe N
    JMIR Public Health Surveill; 2023 Jan; 9():e40080. PubMed ID: 36645706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient Reporting of Adverse Drug Reactions (ADRs): Survey of Public Awareness and Predictors of Confidence to Report.
    Hariraj V; Aziz Z
    Ther Innov Regul Sci; 2018 Nov; 52(6):757-763. PubMed ID: 29714567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why hospital-based healthcare professionals do not report adverse drug reactions: a mixed methods study using the Theoretical Domains Framework.
    Li R; Curtis K; Van C; Tabish Razi Zaidi S; Yeo CY; Arun Kali C; Zaheen M; Therese Moujalli G; Castelino R
    Eur J Clin Pharmacol; 2022 Jul; 78(7):1165-1175. PubMed ID: 35476123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing spontaneous adverse drug reaction reporting in public healthcare setting in Namibia.
    Adenuga BA; Kibuule D; Rennie TW
    Basic Clin Pharmacol Toxicol; 2020 Mar; 126(3):247-253. PubMed ID: 31520574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
    Tandon VR; Mahajan V; Khajuria V; Gillani Z
    Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of awareness about pharmacovigilance and adverse drug reaction monitoring in resident doctors of a tertiary care teaching hospital.
    Pimpalkhute SA; Jaiswal KM; Sontakke SD; Bajait CS; Gaikwad A
    Indian J Med Sci; 2012; 66(3-4):55-61. PubMed ID: 23603621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-care Professionals' Knowledge and Perception of Adverse Drug Reaction Reporting and Pharmacovigilance in a Tertiary Care Teaching Hospital of Nepal.
    Danekhu K; Shrestha S; Aryal S; Shankar PR
    Hosp Pharm; 2021 Jun; 56(3):178-186. PubMed ID: 34024926
    [No Abstract]   [Full Text] [Related]  

  • 14. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.
    Ali MD; Hassan YA; Ahmad A; Alaqel O; Al-Harbi H; Al-Suhaimi NM
    Curr Drug Saf; 2018; 13(1):21-25. PubMed ID: 29256354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare professionals' knowledge, attitude and practice towards adverse drug reaction (ADR) reporting at the health center level in Ethiopia.
    Seid MA; Kasahun AE; Mante BM; Gebremariam SN
    Int J Clin Pharm; 2018 Aug; 40(4):895-902. PubMed ID: 30094559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting.
    Matos C; van Hunsel F; Joaquim J
    Eur J Clin Pharmacol; 2015 Jul; 71(7):883-90. PubMed ID: 26004569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public confidence in ADR identification and their views on ADRreporting: mixed methods study.
    Jarernsiripornkul N; Patsuree A; Krska J
    Eur J Clin Pharmacol; 2017 Feb; 73(2):223-231. PubMed ID: 27837337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge, attitude, practice and barriers towards pharmacovigilance and adverse drug reactions reporting among healthcare professionals in Turkey: a systematic review.
    Khan Z; Karatas Y; Martins MAP; Jamshed S; Rahman H
    Curr Med Res Opin; 2022 Jan; 38(1):145-154. PubMed ID: 34694167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stakeholders' knowledge, attitudes and practices to pharmacovigilance and adverse drug reaction reporting in clinical trials: a mixed methods study.
    Riordan DO; Kinane M; Walsh KA; Shiely F; Eustace J; Bermingham M
    Eur J Clin Pharmacol; 2020 Oct; 76(10):1363-1372. PubMed ID: 32507924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Awareness, knowledge, and attitude toward adverse drug reaction (ADR) reporting among healthcare professionals in Ghana.
    Yawson AA; Abekah-Nkrumah G; Okai GA; Ofori CG
    Ther Adv Drug Saf; 2022; 13():20420986221116468. PubMed ID: 35966898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.